Shao Yu-Wei, Shu Qing, Liu Ruo-Lan, Wang Huan-Mei, Tian Jun
The Second Clinical Medical College, Wuhan University, Wuhan 430071, China.
Rehabilitation Department, Zhongnan Hospital, Wuhan University, Wuhan 430071.
Zhen Ci Yan Jiu. 2020 Jun 25;45(6):438-45. doi: 10.13702/j.1000-0607.190339.
To observe the effect of electroacupuncture (EA) on expression of histone deacetylase 2 (HDAC2), histone H3, bone formation related genes and proteins in osteoporosis rats, so as to reveal its mechanisms underlying improvement of osteoporosis.
Female SD rats were randomly divided into 4 groups: sham operation, model, EA and medication (= 10 rats in each group). The osteoporosis model was established by castration. EA (2 Hz, 1 mA) was applied to bilateral "Shenshu" (BL23) and "Pishu" (BL20) for 10 min, once every other day for 8 weeks. Rats of the medication group received subcutaneous injection of 17 β-estradiol (100 µg/kg, 20 µg/mL). The bone quality and quantity including the cortical bone mineral density (CBMD), trabecular bone mineral density (TBMD), ratio of bone volume /total volume (BV /TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb. Sp), trabecular bone pattern factor (Tb.Pf), and structure model index (SMI) of the right thigh-bone were detected by using a micro-computed tomography. Serum alkaline phosphatase (ALP) and estrogen 2 (E2) contents were assayed by using colorimetry and ELISA, expression levels of HDAC2, histone H3 and Runx2 in the thigh-bone were detected using Western blot, and that of Runx2 mRNA was detected using quantitative real-time PCR, separately. The co-expression of Ac-histone H3/Runx2 and Runx2/ALP was observed by using immunofluorescence histochemical staining.
After modeling, the levels of TBMD, BV/TV, Tb.Th, and Tb.N, serum E2 and ALP, and expression of Runx2 protein and mRNA, Ac-histone and ALP proteins were significantly lower (<0.01), and those of Tb.Sp, Tb.Pf and SMI, HDAC2 and histone H3 proteins were significantly higher (<0.01) in the model group than those in the sham operation group. After the interventions, the decrease of TBMD, BV/TV, Tb.N,Runx2 protein and mRNA,ALP in both EA and medication groups, serum E2 in the medication group, and Ac-histone H3 in the EA group, and the increase of Tb.Sp in the medication group, Tb.Pf, SMI, and HDAC2 in both EA and medication groups, and histone H3 in the EA group were reversed (<0.01, <0.05). No significant changes were found in the levels of CBMD after modeling relevant to the sham operation group, and after EA and medication interventions (>0.05). The effects of EA were significantly superior to 17 β-estradiol in down-regulating the expression of HDAC2 and histone H3 proteins and in up-regulating expression of Ac-histone H3 protein (<0.01,<0.05)..
EA treatment can increase bone density, increase bone mass and trabecular bone, and promote trabecular bone rod-like changes in plate shape in osteoporosis rats, which is related to its effect in up-regulating the expression of Ac-histone H3 protein, and down-regulating the expression of bone formation-related proteins.
观察电针(EA)对骨质疏松大鼠组蛋白去乙酰化酶2(HDAC2)、组蛋白H3、骨形成相关基因及蛋白表达的影响,以揭示其改善骨质疏松的作用机制。
将雌性SD大鼠随机分为4组:假手术组、模型组、电针组和药物组(每组10只)。采用去势法建立骨质疏松模型。电针(2Hz,1mA)双侧“肾俞”(BL23)和“脾俞”(BL20)10分钟,隔日1次,共8周。药物组大鼠皮下注射17β-雌二醇(100μg/kg,20μg/mL)。采用微型计算机断层扫描检测右侧大腿骨的骨质量和数量,包括皮质骨矿物质密度(CBMD)、小梁骨矿物质密度(TBMD)、骨体积/总体积比值(BV/TV)、小梁厚度(Tb.Th)、小梁数量(Tb.N)、小梁间距(Tb.Sp)、小梁骨模式因子(Tb.Pf)和结构模型指数(SMI)。分别采用比色法和酶联免疫吸附测定法检测血清碱性磷酸酶(ALP)和雌激素2(E2)含量,采用蛋白质印迹法检测大腿骨中HDAC2、组蛋白H3和Runx2的表达水平,采用定量实时聚合酶链反应检测Runx2 mRNA的表达水平。采用免疫荧光组织化学染色观察乙酰化组蛋白H3/Runx2和Runx2/ALP的共表达情况。
造模后,模型组的TBMD、BV/TV、Tb.Th和Tb.N水平、血清E2和ALP水平、Runx2蛋白和mRNA表达、乙酰化组蛋白和ALP蛋白表达均显著降低(<0.01),Tb.Sp、Tb.Pf和SMI、HDAC2和组蛋白H3蛋白水平均显著升高(<0.01),与假手术组相比差异有统计学意义。干预后,电针组和药物组的TBMD、BV/TV、Tb.N、Runx2蛋白和mRNA、ALP水平降低,药物组血清E2水平降低,电针组乙酰化组蛋白H3水平降低,药物组Tb.Sp升高,电针组和药物组Tb.Pf、SMI、HDAC2水平升高,电针组组蛋白H3水平升高,差异均有统计学意义(<0.01,<0.05)。与假手术组相比,造模后CBMD水平无显著变化,电针和药物干预后CBMD水平也无显著变化(>0.05)。电针在下调HDAC2和组蛋白H3蛋白表达以及上调乙酰化组蛋白H3蛋白表达方面的效果显著优于17β-雌二醇(<0.01,<0.05)。
电针治疗可增加骨质疏松大鼠的骨密度,增加骨量和小梁骨,促进小梁骨板状向棒状改变,这与其上调乙酰化组蛋白H3蛋白表达、下调骨形成相关蛋白表达的作用有关。